Fourth Ventricular Administration of Immune Checkpoint Inhibitor (Nivolumab) and Methotrexate or 5-Azacytidine for Recurrent Medulloblastoma, Ependymoma, and Other CNS Malignancies

Clinical trial NCT06466798 · WITHDRAWN

Trial details

NCT number: NCT06466798
Sponsor: Jeffrey Treiber
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Recurrent Ependymoma Recurrent Medulloblastoma CNS Malignancies

Start date: 2024-07-15
Primary completion: 2027-07-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.